Cervical (HPV)

Cervical Cancer Testing Tech Could Replace Pap Smears, Save Lives

Emerging techniques could help detect the virus leading to cervical cancer in low-income areas and developing nations.

Cervical (HPV)

Interventional Study to Evaluate Multicancer Early Detection Test

The Pathfinder study will enroll 6,200 participants to evaluate Grail’s investigational multicancer early detection test in clinical practice.

Cervical (HPV)

Qiagen’s CareHPV Test Earns WHO Prequalification Status for Cervical Cancer Screening

WHO prequalification recognizes the important role that the CareHPV test can have in screening women in emerging countries for HPV.

Leading Women’s Healthcare Groups Issue Joint Statement on USPSTF Recommendations

Oct 6, 2017 | Cancer, Cervical (HPV), Molecular Diagnostics, Womens Health

In spite of USPSTF recommendations, ACOG reaffirms its previous guidance in favor of cotesting with cytology and high-risk HPV testing for women aged 30–65 years.

Hologic: USPSTF Draft Cervical Cancer Screening Recommendations Are a Step Back for Women’s Health

Oct 6, 2017 | Cancer, Cervical (HPV)

In a press release, the company argues that proposed screening recommendations would put lives at risk.

Roche Launches HPV Test in Europe

Apr 25, 2017 | Cervical (HPV), Molecular Diagnostics

The HPV DNA assay gives laboratories the ability to run HPV DNA testing simultaneously with other previously released Cobas assays.

Blood Test Holds Promise for Early Diagnosis of Cervical Cancers

Feb 21, 2017 | Cancer, Cervical (HPV), Unknown Origin & Other Cancer Types

Collaborators are set to carry out clinical validation of a blood test for the diagnosis of cancers linked to human papillomavirus.

Screening for Cervical Cancer

Jun 14, 2016 | Cervical (HPV), Disease States

Two real-world studies have confirmed the value of cotesting as the US standard of care.

Cervical Cancer Test Portfolio Delivers Automation with Accuracy

Mar 1, 2016 | Cancer, Cervical (HPV)

The test portfolio aims to complement current screening methods.

HPV Monoclonal Antibodies Function in ELISA

May 26, 2015 | Cancer, Cervical (HPV), Immunoassay

Several monoclonal antibodies in a newly released set are specific to HPV types 16 and 18, while others are pan-specific, reacting with all types tested.

Clinical Results Demonstrate High Sensitivity of Trovagene’s Urine-Based HPV Assay

Feb 9, 2015 | Cervical (HPV), Research

A large-scale study shows the potential for a noninvasive urine-based test to be made available to millions of unscreened women worldwide for the detection of high-risk HPV and precancerous cervical lesions.

Inside Track: The HPV Alternative

Jan 30, 2015 | Cancer, Cervical (HPV), Molecular Diagnostics

Newly issued guidance from the American Society for Colposcopy and Cervical Pathology and the Society for Gynecologic Oncology supports the use of human papilloma virus primary screening for cervical cancer.

ASCCP and SGO Issue Interim Guidance on First-Line HPV Testing

Jan 27, 2015 | Cancer, Cervical (HPV)

End-of-study data from the Athena trial support the option of HPV primary screening for women 25 and older.

CDC: Millions of US Women Are Not Getting Screened for Cervical Cancer

Nov 10, 2014 | Cervical (HPV), Research

A CDC study suggests there is room for improvement in current approaches for screening and prevention of cervical cancer.

First HPV Test Cleared for Cervical Cancer Primary Screening

Jun 23, 2014 | Cancer, Cervical (HPV), Molecular Diagnostics

The Cobas HPV test from Roche Molecular Diagnostics has received FDA clearance for use as a first-line primary screening test for cervical cancer in women 25 and older.